|
ACADSB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.57199994635471E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.68730004915341E-09 |
| Normal-vs-Stage2 |
2.80879997038852E-09 |
| Normal-vs-Stage3 |
1.09270004156059E-09 |
| Normal-vs-Stage4 |
9.28349952467045E-10 |
| Stage1-vs-Stage2 |
9.656000E-01 |
| Stage1-vs-Stage3 |
1.563970E-01 |
| Stage1-vs-Stage4 |
4.037200E-01 |
| Stage2-vs-Stage3 |
2.963800E-01 |
| Stage2-vs-Stage4 |
3.623600E-01 |
| Stage3-vs-Stage4 |
8.640000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.34510000307608E-09 |
| Normal-vs-AfricanAmerican |
4.09970002390736E-09 |
| Normal-vs-Asian |
1.20910004230979E-09 |
| Caucasian-vs-AfricanAmerican |
2.455600E-01 |
| Caucasian-vs-Asian |
4.043400E-01 |
| AfricanAmerican-vs-Asian |
2.940000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81449999470118E-09 |
| Normal-vs-Female |
6.81220002629601E-09 |
| Male-vs-Female |
2.752300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.86130000301432E-09 |
| Normal-vs-Extreme_Weight |
1.03389996564118E-09 |
| Normal-vs-Obese |
2.24179996788365E-09 |
| Normal-vs-Extreme_Obese |
1.68290000046589E-07 |
| Normal_Weight-vs-Extreme_Weight |
2.494000E-01 |
| Normal_Weight-vs-Obese |
8.067800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.086000E-01 |
| Extreme_Weight-vs-Obese |
8.113700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.524610E-01 |
| Obese-vs-Extreme_Obese |
2.102000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.153199979953E-09 |
| Normal-vs-Age(41-60Yrs) |
1.90310001091376E-09 |
| Normal-vs-Age(61-80Yrs) |
2.58290000498818E-09 |
| Normal-vs-Age(81-100Yrs) |
5.57680002177818E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.450800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.321400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.953800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.735800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.816200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.893600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.46930001498902E-09 |
| Normal-VS-Type2 PRCC |
9.95310001083993E-09 |
| Normal-VS-KIRP CIMP |
1.30889998839478E-09 |
| Normal-VS-Unclassified PRCC |
1.98810001794669E-09 |
| Type1 PRCC-VS-Type2 PRCC |
4.465000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.509600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.555400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.852200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.394200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.162400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04709996229246E-09 |
| Normal-vs-N1 |
8.14119993641782E-10 |
| Normal-vs-N2 |
3.81309983588096E-10 |
| N0-vs-N1 |
6.914800E-01 |
| N0-vs-N2 |
2.212000E-01 |
| N1-vs-N2 |
1.920000E-01 |
|
|
